Skip to main content

Table 1 Descriptive Values for Pimobendan Treatment Group

From: Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy

  Baseline Post-pimobendan P value
Murmur2 [(median grade (IQR)] 3 (2,4) 3 (3,4) 0.13
HR1 (mean bpm ± SD) 192.7 ± 29.76 198.5 ± 24.09 0.29
Thickest wall segment1 (mean mm ± SD) 7.28 ± 0.844 6.9 ± 0.853 0.89
Systolic blood pressure2 [median mmHg (IQR)] 125 (109, 130) 127 (113.5, 136.5) 0.36
LAlax1 (mean mm ± SD) 14.7 ± 2.66 15.15 ± 2.66 1.2) 0.20
LVIDd1 (mean mm ± SD) 14.18 ± 1.38 14.51 ± 2.22 0.37
  1. 1Paired T test
  2. 2Wilcoxon matched-pairs signed rank test
  3. IQR, interquartile range; HR, heart rate; bpm, beats per minute; SD, standard deviation; LA, left atrium